| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DVA - DaVita HealthCare Partners Inc | SELL | -80 @ USD 105.84 | USD -8,467 | The ETF sold 80 shares of DVA on 2026-01-15. The shares were previously bought for an average price of USD 138.581. The DaVita HealthCare Partners Inc shares were sold for -23.6% lower than average price of previous purchases. This resulted in an overall loss of USD 2,619 The average price that the ETF previously sold DVA share for is USD 142.13 which is higher than the selling price of USD 105.84 on 2026-01-15. |
| HSIC - Henry Schein Inc | SELL | -232 @ USD 78.08 | USD -18,115 | The ETF sold 232 shares of HSIC on 2026-01-15. The shares were previously bought for an average price of USD 71.5853. The Henry Schein Inc shares were sold for 9.1% higher than average price of previous purchases. This sale made a profit of USD 1,507 The average price that the ETF previously sold HSIC share for is USD 69.8654 so the ETF has sold 232 shares on 2026-01-15 at a higher price than the previous selling average. |
| MOH - MOH | SELL | -112 @ USD 193.74 | USD -21,699 | The ETF sold 112 shares of MOH on 2026-01-15. The shares were previously bought for an average price of USD 228.611. The MOH shares were sold for -15.3% lower than average price of previous purchases. This resulted in an overall loss of USD 3,906 The average price that the ETF previously sold MOH share for is USD 266.08 which is higher than the selling price of USD 193.74 on 2026-01-15. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -112 @ USD 193.74 | USD -21,699 | The ETF sold 112 shares of MOH on 2026-01-15. The shares were previously bought for an average price of USD 228.611. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -15.3% lower than average price of previous purchases. This resulted in an overall loss of USD 3,906 The average price that the ETF previously sold MOH share for is USD 266.08 which is higher than the selling price of USD 193.74 on 2026-01-15. |
| BAX - Baxter International Inc | SELL | -1,148 @ USD 20.37 | USD -23,385 | The ETF sold 1148 shares of BAX on 2026-01-15. The shares were previously bought for an average price of USD 26.6618. The Baxter International Inc shares were sold for -23.6% lower than average price of previous purchases. This resulted in an overall loss of USD 7,223 The average price that the ETF previously sold BAX share for is USD 29.9876 which is higher than the selling price of USD 20.37 on 2026-01-15. |
| CRL - Creightons Plc | SELL | -108 @ USD 223.47 | USD -24,135 | The ETF sold 108 shares of CRL on 2026-01-15. The shares were previously bought for an average price of USD 171.005. The Creightons Plc shares were sold for 30.7% higher than average price of previous purchases. This sale made a profit of USD 5,666 The average price that the ETF previously sold CRL share for is USD 175.514 so the ETF has sold 108 shares on 2026-01-15 at a higher price than the previous selling average. |
| TECH - Bio-Techne Corp | SELL | -348 @ USD 69.96 | USD -24,346 | The ETF sold 348 shares of TECH on 2026-01-15. The shares were previously bought for an average price of USD 60.6529. The Bio-Techne Corp shares were sold for 15.3% higher than average price of previous purchases. This sale made a profit of USD 3,239 The average price that the ETF previously sold TECH share for is USD 65.7153 so the ETF has sold 348 shares on 2026-01-15 at a higher price than the previous selling average. |
| UHS - Universal Health Services Inc | SELL | -120 @ USD 204.19 | USD -24,503 | The ETF sold 120 shares of UHS on 2026-01-15. The shares were previously bought for an average price of USD 198.179. The Universal Health Services Inc shares were sold for 3.0% higher than average price of previous purchases. This sale made a profit of USD 721 The average price that the ETF previously sold UHS share for is USD 198.146 so the ETF has sold 120 shares on 2026-01-15 at a higher price than the previous selling average. |
| ALGN - Align Technology Inc | SELL | -148 @ USD 171.47 | USD -25,378 | The ETF sold 148 shares of ALGN on 2026-01-15. The shares were previously bought for an average price of USD 166.65. The Align Technology Inc shares were sold for 2.9% higher than average price of previous purchases. This sale made a profit of USD 713 The average price that the ETF previously sold ALGN share for is USD 197.708 which is higher than the selling price of USD 171.47 on 2026-01-15. |
| SOLV - Solventum Corp. | SELL | -324 @ USD 80.44 | USD -26,063 | The ETF sold 324 shares of SOLV on 2026-01-15. The shares were previously bought for an average price of USD 74.4564. The Solventum Corp. shares were sold for 8.0% higher than average price of previous purchases. This sale made a profit of USD 1,939 The average price that the ETF previously sold SOLV share for is USD 72.3887 so the ETF has sold 324 shares on 2026-01-15 at a higher price than the previous selling average. |
| RVTY - Revvity Inc. | SELL | -248 @ USD 115.33 | USD -28,602 | The ETF sold 248 shares of RVTY on 2026-01-15. The shares were previously bought for an average price of USD 102.756. The Revvity Inc. shares were sold for 12.2% higher than average price of previous purchases. This sale made a profit of USD 3,118 The average price that the ETF previously sold RVTY share for is USD 106.354 so the ETF has sold 248 shares on 2026-01-15 at a higher price than the previous selling average. |
| MRNA - Moderna Inc | SELL | -764 @ USD 39.36 | USD -30,071 | The ETF sold 764 shares of MRNA on 2026-01-15. The shares were previously bought for an average price of USD 30.4041. The Moderna Inc shares were sold for 29.5% higher than average price of previous purchases. This sale made a profit of USD 6,842 The average price that the ETF previously sold MRNA share for is USD 36.8911 so the ETF has sold 764 shares on 2026-01-15 at a higher price than the previous selling average. |
| VTRS - Viatris Inc | SELL | -2,564 @ USD 12.84 | USD -32,922 | The ETF sold 2564 shares of VTRS on 2026-01-15. The shares were previously bought for an average price of USD 10.5152. The Viatris Inc shares were sold for 22.1% higher than average price of previous purchases. This sale made a profit of USD 5,961 The average price that the ETF previously sold VTRS share for is USD 11.1596 so the ETF has sold 2564 shares on 2026-01-15 at a higher price than the previous selling average. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -440 @ USD 82.31 | USD -36,216 | The ETF sold 440 shares of COO on 2026-01-15. The shares were previously bought for an average price of USD 80.8446. The The Cooper Companies, Inc. Common Stock shares were sold for 1.8% higher than average price of previous purchases. This sale made a profit of USD 645 The average price that the ETF previously sold COO share for is USD 88.37 which is higher than the selling price of USD 82.31 on 2026-01-15. |
| HOLX - Hologic Inc | SELL | -492 @ USD 75.02 | USD -36,910 | The ETF sold 492 shares of HOLX on 2026-01-15. The shares were previously bought for an average price of USD 69.1365. The Hologic Inc shares were sold for 8.5% higher than average price of previous purchases. This sale made a profit of USD 2,895 The average price that the ETF previously sold HOLX share for is USD 71.0784 so the ETF has sold 492 shares on 2026-01-15 at a higher price than the previous selling average. |
| INCY - Incyte Corporation | SELL | -364 @ USD 105.24 | USD -38,307 | The ETF sold 364 shares of INCY on 2026-01-15. The shares were previously bought for an average price of USD 82.0502. The Incyte Corporation shares were sold for 28.3% higher than average price of previous purchases. This sale made a profit of USD 8,441 The average price that the ETF previously sold INCY share for is USD 76.1403 so the ETF has sold 364 shares on 2026-01-15 at a higher price than the previous selling average. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -440 @ USD 88.75 | USD -39,050 | The ETF sold 440 shares of ZBH on 2026-01-15. The shares were previously bought for an average price of USD 100.606. The Zimmer Biomet Holdings Inc shares were sold for -11.8% lower than average price of previous purchases. This resulted in an overall loss of USD 5,217 The average price that the ETF previously sold ZBH share for is USD 103.202 which is higher than the selling price of USD 88.75 on 2026-01-15. |
| PODD - Insulet Corporation | SELL | -156 @ USD 286.49 | USD -44,692 | The ETF sold 156 shares of PODD on 2026-01-15. The shares were previously bought for an average price of USD 295.366. The Insulet Corporation shares were sold for -3.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,385 The average price that the ETF previously sold PODD share for is USD 277.637 so the ETF has sold 156 shares on 2026-01-15 at a higher price than the previous selling average. |
| WST - West Pharmaceutical Services Inc | SELL | -160 @ USD 279.41 | USD -44,706 | The ETF sold 160 shares of WST on 2026-01-15. The shares were previously bought for an average price of USD 260.135. The West Pharmaceutical Services Inc shares were sold for 7.4% higher than average price of previous purchases. This sale made a profit of USD 3,084 The average price that the ETF previously sold WST share for is USD 284.772 which is higher than the selling price of USD 279.41 on 2026-01-15. |
| DGX - Quest Diagnostics Incorporated | SELL | -248 @ USD 190.26 | USD -47,184 | The ETF sold 248 shares of DGX on 2026-01-15. The shares were previously bought for an average price of USD 175.831. The Quest Diagnostics Incorporated shares were sold for 8.2% higher than average price of previous purchases. This sale made a profit of USD 3,578 The average price that the ETF previously sold DGX share for is USD 166.065 so the ETF has sold 248 shares on 2026-01-15 at a higher price than the previous selling average. |
| CNC - Concurrent Technologies Plc | SELL | -1,032 @ USD 47.27 | USD -48,783 | The ETF sold 1032 shares of CNC on 2026-01-15. The shares were previously bought for an average price of USD 46.2001. The Concurrent Technologies Plc shares were sold for 2.3% higher than average price of previous purchases. This sale made a profit of USD 1,104 The average price that the ETF previously sold CNC share for is USD 52.2584 which is higher than the selling price of USD 47.27 on 2026-01-15. |
| LH - Laboratory Corporation of America Holdings | SELL | -184 @ USD 268.89 | USD -49,476 | The ETF sold 184 shares of LH on 2026-01-15. The shares were previously bought for an average price of USD 257.314. The Laboratory Corporation of America Holdings shares were sold for 4.5% higher than average price of previous purchases. This sale made a profit of USD 2,130 The average price that the ETF previously sold LH share for is USD 243.86 so the ETF has sold 184 shares on 2026-01-15 at a higher price than the previous selling average. |
| WAT - Waters Corporation | SELL | -132 @ USD 394.59 | USD -52,086 | The ETF sold 132 shares of WAT on 2026-01-15. The shares were previously bought for an average price of USD 355.311. The Waters Corporation shares were sold for 11.1% higher than average price of previous purchases. This sale made a profit of USD 5,185 The average price that the ETF previously sold WAT share for is USD 365.812 so the ETF has sold 132 shares on 2026-01-15 at a higher price than the previous selling average. |
| WAT - MULETFWATIMETFP | SELL | -132 @ USD 394.59 | USD -52,086 | The ETF sold 132 shares of WAT on 2026-01-15. The shares were previously bought for an average price of USD 355.311. The MULETFWATIMETFP shares were sold for 11.1% higher than average price of previous purchases. This sale made a profit of USD 5,185 The average price that the ETF previously sold WAT share for is USD 365.812 so the ETF has sold 132 shares on 2026-01-15 at a higher price than the previous selling average. |
| BIIB - Biogen Inc | SELL | -324 @ USD 168.57 | USD -54,617 | The ETF sold 324 shares of BIIB on 2026-01-15. The shares were previously bought for an average price of USD 149.405. The Biogen Inc shares were sold for 12.8% higher than average price of previous purchases. This sale made a profit of USD 6,209 The average price that the ETF previously sold BIIB share for is USD 153.926 so the ETF has sold 324 shares on 2026-01-15 at a higher price than the previous selling average. |
| STE - STERIS plc | SELL | -220 @ USD 268.26 | USD -59,017 | The ETF sold 220 shares of STE on 2026-01-15. The shares were previously bought for an average price of USD 239.082. The STERIS plc shares were sold for 12.2% higher than average price of previous purchases. This sale made a profit of USD 6,419 The average price that the ETF previously sold STE share for is USD 225.238 so the ETF has sold 220 shares on 2026-01-15 at a higher price than the previous selling average. |
| DXCM - DexCom Inc | SELL | -868 @ USD 69.24 | USD -60,100 | The ETF sold 868 shares of DXCM on 2026-01-15. The shares were previously bought for an average price of USD 73.6279. The DexCom Inc shares were sold for -6.0% lower than average price of previous purchases. This resulted in an overall loss of USD 3,809 The average price that the ETF previously sold DXCM share for is USD 75.9069 which is higher than the selling price of USD 69.24 on 2026-01-15. |
| MTD - Mettler-Toledo International Inc | SELL | -44 @ USD 1496.61 | USD -65,851 | The ETF sold 44 shares of MTD on 2026-01-15. The shares were previously bought for an average price of USD 1309.61. The Mettler-Toledo International Inc shares were sold for 14.3% higher than average price of previous purchases. This sale made a profit of USD 8,228 The average price that the ETF previously sold MTD share for is USD 1256.96 so the ETF has sold 44 shares on 2026-01-15 at a higher price than the previous selling average. |
| MTD - AMUNDI EUR GOV 710 | SELL | -44 @ USD 1496.61 | USD -65,851 | The ETF sold 44 shares of MTD on 2026-01-15. The shares were previously bought for an average price of USD 1309.61. The AMUNDI EUR GOV 710 shares were sold for 14.3% higher than average price of previous purchases. This sale made a profit of USD 8,228 The average price that the ETF previously sold MTD share for is USD 1256.96 so the ETF has sold 44 shares on 2026-01-15 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -264 @ USD 283.95 | USD -74,963 | The ETF sold 264 shares of HUM on 2026-01-15. The shares were previously bought for an average price of USD 265.611. The Hummingbird Resources PLC shares were sold for 6.9% higher than average price of previous purchases. This sale made a profit of USD 4,841 The average price that the ETF previously sold HUM share for is USD 267.131 so the ETF has sold 264 shares on 2026-01-15 at a higher price than the previous selling average. |
| HUM - Humana Inc | SELL | -264 @ USD 283.95 | USD -74,963 | The ETF sold 264 shares of HUM on 2026-01-15. The shares were previously bought for an average price of USD 265.611. The Humana Inc shares were sold for 6.9% higher than average price of previous purchases. This sale made a profit of USD 4,841 The average price that the ETF previously sold HUM share for is USD 267.131 so the ETF has sold 264 shares on 2026-01-15 at a higher price than the previous selling average. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -1,004 @ USD 82.51 | USD -82,840 | The ETF sold 1004 shares of GEHC on 2026-01-15. The shares were previously bought for an average price of USD 79.677. The GE HealthCare Technologies Inc. shares were sold for 3.6% higher than average price of previous purchases. This sale made a profit of USD 2,844 The average price that the ETF previously sold GEHC share for is USD 79.3523 so the ETF has sold 1004 shares on 2026-01-15 at a higher price than the previous selling average. |
| RMD - ResMed Inc | SELL | -324 @ USD 260.7 | USD -84,467 | The ETF sold 324 shares of RMD on 2026-01-15. The shares were previously bought for an average price of USD 251.595. The ResMed Inc shares were sold for 3.6% higher than average price of previous purchases. This sale made a profit of USD 2,950 The average price that the ETF previously sold RMD share for is USD 244.898 so the ETF has sold 324 shares on 2026-01-15 at a higher price than the previous selling average. |
| A - Agilent Technologies Inc | SELL | -624 @ USD 144.83 | USD -90,374 | The ETF sold 624 shares of A on 2026-01-15. The shares were previously bought for an average price of USD 131.885. The Agilent Technologies Inc shares were sold for 9.8% higher than average price of previous purchases. This sale made a profit of USD 8,078 The average price that the ETF previously sold A share for is USD 132.014 so the ETF has sold 624 shares on 2026-01-15 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -376 @ USD 241.28 | USD -90,721 | The ETF sold 376 shares of IQV on 2026-01-15. The shares were previously bought for an average price of USD 198.657. The IQVIA Holdings Inc shares were sold for 21.5% higher than average price of previous purchases. This sale made a profit of USD 16,026 The average price that the ETF previously sold IQV share for is USD 192.422 so the ETF has sold 376 shares on 2026-01-15 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -1,284 @ USD 84.49 | USD -108,485 | The ETF sold 1284 shares of EW on 2026-01-15. The shares were previously bought for an average price of USD 76.309. The Edwards Lifesciences Corp shares were sold for 10.7% higher than average price of previous purchases. This sale made a profit of USD 10,504 The average price that the ETF previously sold EW share for is USD 73.4667 so the ETF has sold 1284 shares on 2026-01-15 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -520 @ USD 213.46 | USD -110,999 | The ETF sold 520 shares of CAH on 2026-01-15. The shares were previously bought for an average price of USD 157.036. The Cardinal Health Inc shares were sold for 35.9% higher than average price of previous purchases. This sale made a profit of USD 29,340 The average price that the ETF previously sold CAH share for is USD 141.078 so the ETF has sold 520 shares on 2026-01-15 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -980 @ USD 125.28 | USD -122,774 | The ETF sold 980 shares of ZTS on 2026-01-15. The shares were previously bought for an average price of USD 149.502. The Zoetis Inc shares were sold for -16.2% lower than average price of previous purchases. This resulted in an overall loss of USD 23,738 The average price that the ETF previously sold ZTS share for is USD 162.707 which is higher than the selling price of USD 125.28 on 2026-01-15. |
| IDXX - IDEXX Laboratories Inc | SELL | -176 @ USD 712.12 | USD -125,333 | The ETF sold 176 shares of IDXX on 2026-01-15. The shares were previously bought for an average price of USD 579.741. The IDEXX Laboratories Inc shares were sold for 22.8% higher than average price of previous purchases. This sale made a profit of USD 23,299 The average price that the ETF previously sold IDXX share for is USD 489.85 so the ETF has sold 176 shares on 2026-01-15 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -632 @ USD 208.35 | USD -131,677 | The ETF sold 632 shares of BDX on 2026-01-15. The shares were previously bought for an average price of USD 204.393. The Becton Dickinson and Company shares were sold for 1.9% higher than average price of previous purchases. This sale made a profit of USD 2,501 The average price that the ETF previously sold BDX share for is USD 208.807 which is higher than the selling price of USD 208.35 on 2026-01-15. |
| COR - Cencora Inc. | SELL | -428 @ USD 355.35 | USD -152,090 | The ETF sold 428 shares of COR on 2026-01-15. The shares were previously bought for an average price of USD 304.415. The Cencora Inc. shares were sold for 16.7% higher than average price of previous purchases. This sale made a profit of USD 21,800 The average price that the ETF previously sold COR share for is USD 272.217 so the ETF has sold 428 shares on 2026-01-15 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -592 @ USD 277.94 | USD -164,540 | The ETF sold 592 shares of CI on 2026-01-15. The shares were previously bought for an average price of USD 296.52. The Cigna Corp shares were sold for -6.3% lower than average price of previous purchases. This resulted in an overall loss of USD 10,999 The average price that the ETF previously sold CI share for is USD 307.285 which is higher than the selling price of USD 277.94 on 2026-01-15. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -224 @ USD 741.92 | USD -166,190 | The ETF sold 224 shares of REGN on 2026-01-15. The shares were previously bought for an average price of USD 666.878. The Regeneron Pharmaceuticals Inc shares were sold for 11.3% higher than average price of previous purchases. This sale made a profit of USD 16,809 The average price that the ETF previously sold REGN share for is USD 692.76 so the ETF has sold 224 shares on 2026-01-15 at a higher price than the previous selling average. |
| HCA - HCA Holdings Inc | SELL | -352 @ USD 483.8 | USD -170,298 | The ETF sold 352 shares of HCA on 2026-01-15. The shares were previously bought for an average price of USD 396.88. The HCA Holdings Inc shares were sold for 21.9% higher than average price of previous purchases. This sale made a profit of USD 30,596 The average price that the ETF previously sold HCA share for is USD 368.421 so the ETF has sold 352 shares on 2026-01-15 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -492 @ USD 381.93 | USD -187,910 | The ETF sold 492 shares of ELV on 2026-01-15. The shares were previously bought for an average price of USD 365.393. The Elevance Health Inc shares were sold for 4.5% higher than average price of previous purchases. This sale made a profit of USD 8,136 The average price that the ETF previously sold ELV share for is USD 383.864 which is higher than the selling price of USD 381.93 on 2026-01-15. |
| ELV - Elevance Health Inc | SELL | -492 @ USD 381.93 | USD -187,910 | The ETF sold 492 shares of ELV on 2026-01-15. The shares were previously bought for an average price of USD 365.393. The Elevance Health Inc shares were sold for 4.5% higher than average price of previous purchases. This sale made a profit of USD 8,136 The average price that the ETF previously sold ELV share for is USD 383.864 which is higher than the selling price of USD 381.93 on 2026-01-15. |
| CVS - CVS Health Corp | SELL | -2,808 @ USD 81.36 | USD -228,459 | The ETF sold 2808 shares of CVS on 2026-01-15. The shares were previously bought for an average price of USD 70.647. The CVS Health Corp shares were sold for 15.2% higher than average price of previous purchases. This sale made a profit of USD 30,082 The average price that the ETF previously sold CVS share for is USD 60.7367 so the ETF has sold 2808 shares on 2026-01-15 at a higher price than the previous selling average. |
| MCK - McKesson Corporation | SELL | -272 @ USD 844.13 | USD -229,603 | The ETF sold 272 shares of MCK on 2026-01-15. The shares were previously bought for an average price of USD 717.323. The McKesson Corporation shares were sold for 17.7% higher than average price of previous purchases. This sale made a profit of USD 34,492 The average price that the ETF previously sold MCK share for is USD 656.378 so the ETF has sold 272 shares on 2026-01-15 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -560 @ USD 438.92 | USD -245,795 | The ETF sold 560 shares of VRTX on 2026-01-15. The shares were previously bought for an average price of USD 443.225. The Vertex Pharmaceuticals Inc shares were sold for -1.0% lower than average price of previous purchases. This resulted in an overall loss of USD 2,411 The average price that the ETF previously sold VRTX share for is USD 457.456 which is higher than the selling price of USD 438.92 on 2026-01-15. |
| BMY - Bloomsbury Publishing Plc | SELL | -4,500 @ USD 56.62 | USD -254,790 | The ETF sold 4500 shares of BMY on 2026-01-15. The shares were previously bought for an average price of USD 52.0135. The Bloomsbury Publishing Plc shares were sold for 8.9% higher than average price of previous purchases. This sale made a profit of USD 20,729 The average price that the ETF previously sold BMY share for is USD 53.4557 so the ETF has sold 4500 shares on 2026-01-15 at a higher price than the previous selling average. |
| SYK - Stryker Corporation | SELL | -760 @ USD 362.49 | USD -275,492 | The ETF sold 760 shares of SYK on 2026-01-15. The shares were previously bought for an average price of USD 372.801. The Stryker Corporation shares were sold for -2.8% lower than average price of previous purchases. This resulted in an overall loss of USD 7,836 The average price that the ETF previously sold SYK share for is USD 376.055 which is higher than the selling price of USD 362.49 on 2026-01-15. |
| MDT - Medtronic PLC | SELL | -2,836 @ USD 99 | USD -280,764 | The ETF sold 2836 shares of MDT on 2026-01-15. The shares were previously bought for an average price of USD 92.6003. The Medtronic PLC shares were sold for 6.9% higher than average price of previous purchases. This sale made a profit of USD 18,150 The average price that the ETF previously sold MDT share for is USD 87.7127 so the ETF has sold 2836 shares on 2026-01-15 at a higher price than the previous selling average. |
| BSX - Boston Scientific Corporation | SELL | -3,276 @ USD 90.03 | USD -294,938 | The ETF sold 3276 shares of BSX on 2026-01-15. The shares were previously bought for an average price of USD 98.9586. The Boston Scientific Corporation shares were sold for -9.0% lower than average price of previous purchases. This resulted in an overall loss of USD 29,250 The average price that the ETF previously sold BSX share for is USD 94.3719 which is higher than the selling price of USD 90.03 on 2026-01-15. |
| BSX - MULSTRXSSXIMETFP | SELL | -3,276 @ USD 90.03 | USD -294,938 | The ETF sold 3276 shares of BSX on 2026-01-15. The shares were previously bought for an average price of USD 98.9586. The MULSTRXSSXIMETFP shares were sold for -9.0% lower than average price of previous purchases. This resulted in an overall loss of USD 29,250 The average price that the ETF previously sold BSX share for is USD 94.3719 which is higher than the selling price of USD 90.03 on 2026-01-15. |
| PFE - Pfizer Inc | SELL | -12,568 @ USD 25.89 | USD -325,386 | The ETF sold 12568 shares of PFE on 2026-01-15. The shares were previously bought for an average price of USD 25.3797. The Pfizer Inc shares were sold for 2.0% higher than average price of previous purchases. This sale made a profit of USD 6,413 The average price that the ETF previously sold PFE share for is USD 25.5253 so the ETF has sold 12568 shares on 2026-01-15 at a higher price than the previous selling average. |
| GILD - Guild Esports Plc | SELL | -2,740 @ USD 121.26 | USD -332,252 | The ETF sold 2740 shares of GILD on 2026-01-15. The shares were previously bought for an average price of USD 112.56. The Guild Esports Plc shares were sold for 7.7% higher than average price of previous purchases. This sale made a profit of USD 23,838 The average price that the ETF previously sold GILD share for is USD 101.658 so the ETF has sold 2740 shares on 2026-01-15 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -1,388 @ USD 239.89 | USD -332,967 | The ETF sold 1388 shares of DHR on 2026-01-15. The shares were previously bought for an average price of USD 215.44. The Danaher Corporation shares were sold for 11.3% higher than average price of previous purchases. This sale made a profit of USD 33,937 The average price that the ETF previously sold DHR share for is USD 223.633 so the ETF has sold 1388 shares on 2026-01-15 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -1,388 @ USD 239.89 | USD -332,967 | The ETF sold 1388 shares of DHR on 2026-01-15. The shares were previously bought for an average price of USD 215.44. The Danaher Corporation shares were sold for 11.3% higher than average price of previous purchases. This sale made a profit of USD 33,937 The average price that the ETF previously sold DHR share for is USD 223.633 so the ETF has sold 1388 shares on 2026-01-15 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -1,188 @ USD 330.03 | USD -392,076 | The ETF sold 1188 shares of AMGN on 2026-01-15. The shares were previously bought for an average price of USD 306.001. The Amgen Inc shares were sold for 7.9% higher than average price of previous purchases. This sale made a profit of USD 28,546 The average price that the ETF previously sold AMGN share for is USD 293.644 so the ETF has sold 1188 shares on 2026-01-15 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -784 @ USD 541.34 | USD -424,411 | The ETF sold 784 shares of ISRG on 2026-01-15. The shares were previously bought for an average price of USD 523.243. The Intuitive Surgical Inc shares were sold for 3.5% higher than average price of previous purchases. This sale made a profit of USD 14,188 The average price that the ETF previously sold ISRG share for is USD 532.64 so the ETF has sold 784 shares on 2026-01-15 at a higher price than the previous selling average. |
| ABT - Abbott Laboratories | SELL | -3,840 @ USD 123.53 | USD -474,355 | The ETF sold 3840 shares of ABT on 2026-01-15. The shares were previously bought for an average price of USD 128.479. The Abbott Laboratories shares were sold for -3.9% lower than average price of previous purchases. This resulted in an overall loss of USD 19,004 The average price that the ETF previously sold ABT share for is USD 122.237 so the ETF has sold 3840 shares on 2026-01-15 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -828 @ USD 624.65 | USD -517,210 | The ETF sold 828 shares of TMO on 2026-01-15. The shares were previously bought for an average price of USD 525.605. The Time Out Group plc shares were sold for 18.8% higher than average price of previous purchases. This sale made a profit of USD 82,009 The average price that the ETF previously sold TMO share for is USD 507.267 so the ETF has sold 828 shares on 2026-01-15 at a higher price than the previous selling average. |
| MRK - Marks Electrical Group PLC | SELL | -5,488 @ USD 110.97 | USD -609,003 | The ETF sold 5488 shares of MRK on 2026-01-15. The shares were previously bought for an average price of USD 91.0179. The Marks Electrical Group PLC shares were sold for 21.9% higher than average price of previous purchases. This sale made a profit of USD 109,497 The average price that the ETF previously sold MRK share for is USD 94.519 so the ETF has sold 5488 shares on 2026-01-15 at a higher price than the previous selling average. |
| MRK - Merck & Company Inc | SELL | -5,488 @ USD 110.97 | USD -609,003 | The ETF sold 5488 shares of MRK on 2026-01-15. The shares were previously bought for an average price of USD 91.0179. The Merck & Company Inc shares were sold for 21.9% higher than average price of previous purchases. This sale made a profit of USD 109,497 The average price that the ETF previously sold MRK share for is USD 94.519 so the ETF has sold 5488 shares on 2026-01-15 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -2,000 @ USD 338.96 | USD -677,920 | The ETF sold 2000 shares of UNH on 2026-01-15. The shares were previously bought for an average price of USD 402.075. The UnitedHealth Group Incorporated shares were sold for -15.7% lower than average price of previous purchases. This resulted in an overall loss of USD 126,230 The average price that the ETF previously sold UNH share for is USD 471.293 which is higher than the selling price of USD 338.96 on 2026-01-15. |
| ABBV - AbbVie Inc | SELL | -3,900 @ USD 216.75 | USD -845,325 | The ETF sold 3900 shares of ABBV on 2026-01-15. The shares were previously bought for an average price of USD 208.23. The AbbVie Inc shares were sold for 4.1% higher than average price of previous purchases. This sale made a profit of USD 33,228 The average price that the ETF previously sold ABBV share for is USD 192.227 so the ETF has sold 3900 shares on 2026-01-15 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -5,320 @ USD 219.57 | USD -1,168,112 | The ETF sold 5320 shares of JNJ on 2026-01-15. The shares were previously bought for an average price of USD 177.342. The Johnson & Johnson shares were sold for 23.8% higher than average price of previous purchases. This sale made a profit of USD 224,653 The average price that the ETF previously sold JNJ share for is USD 160.426 so the ETF has sold 5320 shares on 2026-01-15 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -1,752 @ USD 1032.97 | USD -1,809,763 | The ETF sold 1752 shares of LLY on 2026-01-15. The shares were previously bought for an average price of USD 862.425. The Eli Lilly and Company shares were sold for 19.8% higher than average price of previous purchases. This sale made a profit of USD 298,795 The average price that the ETF previously sold LLY share for is USD 819.771 so the ETF has sold 1752 shares on 2026-01-15 at a higher price than the previous selling average. |